Education
- 2016: National Academic Qualification as Associate Professor
- 2013: Urologist, 70/70 cum laude
- 2013: Clinical fellowship at the Department of Urology, Karolinska Institutet, Stockholm, Sweden
- 2012 – 2013: Clinical fellowship at the Department of Urology, Istituto Nazionale Tumori, Milano
- 2008 – 2013: Urology resident at the Department of Urology, San Raffaele Turro, Milan
- 2008 – 2009: Research fellowship at Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal
- 2005 – 2008: Medical volunteer at the Department of Urology, Vita-Salute San Raffaele Hospital, Milan
- 2001 – 2007: Medical student at Vita-Salute San Raffaele University, Milan
- 2007: Medical doctor Degree, 110 cum laude
- 2004 – 2005: Medical volunteer at the Department of Endocrinology, Vita-Salute San Raffaele Hospital, Milan
Academic Appointments
- 2022 – present: Associate Professor of Urology; Humanitas University
- 2018 – 2022: Assistant Professor; MD Course; Humanitas University
- 2015 – 2018: Adjunt Professor; MD Course; Humanitas University
- 2013 – 2014: Adjunt Professor; International MD Program; Vita-Salute San Raffaele University
- Research on the prognostic factors of several urological malignancies (mainly focusing on prostate cancer, kidney cancer and upper tract urothelial cancer)
- Research on biomarkers and novel diagnostic strategies for prostate cancer detection and characterization.
- Research on novel treatment strategies for benign prostatic hyperplasia.
- Research on robotic surgery techniques and outcomes.
- Lughezzani G, Capitanio U, Jeldres C, Isbarn H, Shariat SF, Arjane P, Widmer H, Perrotte P, Montorsi F, Karakiewicz PI. Prognostic significance of lymph node invasion in patients with metastatic renal cell carcinoma: a population-based perspective. Cancer. 2009 Dec 15;115(24):5680-7. doi: 10.1002/cncr.24682. PubMed PMID: 19824083.
- Lughezzani G, Sun M, Budäus L, Thuret R, Perrotte P, Karakiewicz PI. Population-based external validation of a competing-risks nomogram for patients with localized renal cell carcinoma. J Clin Oncol. 2010 Jun 20;28(18):e299-300; author reply e301. doi: 10.1200/JCO.2009.27.6345. Epub 2010 May 17. PubMed PMID: 20479402.
- Lughezzani G, Burger M, Margulis V, Matin SF, Novara G, Roupret M, Shariat SF, Wood CG, Zigeuner R. Prognostic factors in upper urinary tract urothelial carcinomas: a comprehensive review of the current literature. Eur Urol. 2012 Jul;62(1):100-14. doi: 10.1016/j.eururo.2012.02.030. Epub 2012 Feb 23. Review. PubMed PMID: 22381168.
- Lughezzani G, Lazzeri M, Larcher A, Lista G, Scattoni V, Cestari A, Buffi NM, Bini V, Guazzoni G. Development and internal validation of a Prostate Health Index based nomogram for predicting prostate cancer at extended biopsy. J Urol. 2012 Oct;188(4):1144-50. doi: 10.1016/j.juro.2012.06.025. Epub 2012 Aug 15. PubMed PMID: 22901589.
- Lughezzani G, Lazzeri M, Haese A, McNicholas T, de la Taille A, Buffi NM, Fossati N, Lista G, Larcher A, Abrate A, Mistretta A, Bini V, Palou Redorta J, Graefen M, Guazzoni G. Multicenter European external validation of a prostate health index-based nomogram for predicting prostate cancer at extended biopsy. Eur Urol. 2014 Nov;66(5):906-12. doi: 10.1016/j.eururo.2013.12.005. Epub 2013 Dec 16. PubMed PMID: 24361258.